Dr. Terry Hsieh, MD, PhD

Dr. Hsieh practices at Southern California Permanente Medical Group in Anaheim, California.

Dr. Hsieh's NPI, 1497251367, was assigned on April 1, 2018. Dr. Hsieh graduated from Boston University School Of Medicine in 2018. Dr. Hsieh's California license number on file is A164534.

Dr. Hsieh's primary practice is Southern California Permanente Medical Group, at 441 N Lakeview Ave, Anaheim, CA 92807 in Orange County. The practice phone is (714) 279-4000.

Dr. Hsieh's primary practice is Southern California Permanente Medical Group in Anaheim, California. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Dr. Hsieh to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hsieh practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Hsieh's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Hsieh is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Hsieh has a license on file in California.

Dmand AI lists surgical retina and vitreous procedures and vision problems among the conditions Dr. Hsieh treats.

CMS data shows 27 Medicare services from Dr. Hsieh across 1 procedure code in 2023, for 47 Medicare patients. Medicare paid $461 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 47 Medicare patients who saw Dr. Hsieh in 2024. The largest group is 65 to 74, with 20 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hsieh's median patient age at 66, with 53% women.

In 2024, Dr. Hsieh wrote 148 Medicare Part D claims for 54 patients. 72% of them were for generic drugs. CMS names the drug for 123 of them, across 7 drugs with 11 or more claims each, at $6,185 in total drug cost. In 2023, CMS named 347 claims across 9 drugs.

Dr. Hsieh accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Hsieh, published from 2010 to 2021. 2021 was the busiest year, with 2. The most frequent topics are Antineoplastic Agents, Alkylating, Intravitreal Injections and Melphalan. Dr. Hsieh has published most often in Am J Pathol. Dr. Hsieh's most frequent co-authors are David H H. Abramson, MD, Jasmine H. Francis, MD and Anthony Brent Daniels, MD.

CMS Open Payments shows 30 general payments to Dr. Hsieh from 11 drug and device companies from 2021 to 2025. Consulting fees make up the largest share, 60% of the total. Genentech, Inc. paid the most, $5,810.

Dr. Hsieh graduated from Boston University School Of Medicine in 2018.

Dr. Hsieh is in network with 5 carriers, including Blue Cross Blue Shield of Michigan, Kaiser Permanente and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.